Preliminary biological evaluation of novel 99mTc-Cys-annexin a5 as a apoptosis imaging agent

12Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A novel annexin A5 derivative (cys-annexin A5) with a single cysteine residue at its C-terminal has been developed and successfully labeled in high labeling yield with 99mTc by a ligand exchange reaction. Like the 1st generation 99mTc-HYNIC-annexin A5, the novel 99mTc-cys- annexin A5 derivative shows in normal mice mainly renal and, to a lesser extent, hepatobiliary excretion. In rat models of hepatic apoptosis there was 283% increase in hepatic uptake of 99mTc-cys-annexin A5 as compared to normal mice. The results indicate that the novel 99mTc-cys-annexin A5 is a potential apoptosis imaging agent. © 2013 by the authors.

Cite

CITATION STYLE

APA

Lu, C., Jiang, Q., Hu, M., Tan, C., Ji, Y., Yu, H., & Hua, Z. (2013). Preliminary biological evaluation of novel 99mTc-Cys-annexin a5 as a apoptosis imaging agent. Molecules, 18(6), 6908–6918. https://doi.org/10.3390/molecules18066908

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free